Clinical Trials Browser

Phase 2 × Muscle Invasive Bladder Cancer × liposomal doxorubicin × Clear all

NCT04101812 2019-09-26

Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer

Phase 2 Unknown

Muscle Invasive Bladder Cancer